VERV
Verve Therapeutics
VERV
VERV
Delisted
VERV was delisted on the 24th of July, 2025.
166 hedge funds and large institutions have $444M invested in Verve Therapeutics in 2024 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 63 increasing their positions, 54 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
5% less funds holding
Funds holding: 174 → 166 (-8)
21% less call options, than puts
Call options by funds: $734K | Put options by funds: $926K
23% less first-time investments, than exits
New positions opened: 20 | Existing positions closed: 26
Holders
166
Holding in Top 10
2
Calls
$734K
Puts
$926K
Top Buyers
| 1 | +$35.3M | |
| 2 | +$7.86M | |
| 3 | +$7.8M | |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$1.63M |
| 5 |
BlackRock
New York
|
+$1.41M |
Top Sellers
| 1 | -$6.94M | |
| 2 | -$5.89M | |
| 3 | -$5.74M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$3.47M |
| 5 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
-$3.16M |